- Home
- CHGG vs LYEL Comparison
CHGG vs LYEL Comparison
Compare CHGG & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- LYEL
- Stock Information
- Founded
- CHGG 2005
- LYEL 2018
- Country
- CHGG United States
- LYEL United States
- Employees
- CHGG N/A
- LYEL N/A
- Industry
- CHGG Other Consumer Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- CHGG Real Estate
- LYEL Health Care
- Exchange
- CHGG Nasdaq
- LYEL Nasdaq
- Market Cap
- CHGG 175.2M
- LYEL 203.9M
- IPO Year
- CHGG 2013
- LYEL 2021
- Fundamental
- Price
- CHGG $1.48
- LYEL $0.58
- Analyst Decision
- CHGG Hold
- LYEL Sell
- Analyst Count
- CHGG 10
- LYEL 2
- Target Price
- CHGG $4.56
- LYEL $1.00
- AVG Volume (30 Days)
- CHGG 3.0M
- LYEL 1.1M
- Earning Date
- CHGG 02-03-2025
- LYEL 02-26-2025
- Dividend Yield
- CHGG N/A
- LYEL N/A
- EPS Growth
- CHGG N/A
- LYEL N/A
- EPS
- CHGG N/A
- LYEL N/A
- Revenue
- CHGG $662,077,000.00
- LYEL $63,000.00
- Revenue This Year
- CHGG N/A
- LYEL N/A
- Revenue Next Year
- CHGG N/A
- LYEL N/A
- P/E Ratio
- CHGG N/A
- LYEL N/A
- Revenue Growth
- CHGG N/A
- LYEL N/A
- 52 Week Low
- CHGG $1.34
- LYEL $0.55
- 52 Week High
- CHGG $10.50
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- CHGG 38.42
- LYEL 34.70
- Support Level
- CHGG $1.43
- LYEL $0.55
- Resistance Level
- CHGG $1.79
- LYEL $0.62
- Average True Range (ATR)
- CHGG 0.13
- LYEL 0.04
- MACD
- CHGG -0.01
- LYEL 0.01
- Stochastic Oscillator
- CHGG 11.36
- LYEL 14.24
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.